NEW YORK, Dec. 30, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Skye Bioscience, Inc. (“Skye Bioscience, Inc.” or the “Company”) (NASDAQ: SKYE) of a class action securities lawsuit.
One person was taken to the hospital after their vehicle went over the southbound guardrail on I-77, engulfing in flames.
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025, both dates inclusive (the ...
NEW YORK, Dec. 29, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Skye Bioscience, Inc ...
Summary • Skye Bioscience, Inc. (SKYE) shares rose 8.6% in pre-market to $0.8687 despite ongoing class action lawsuits. • Multiple law firms are reminding investors of deadlines to join legal ...
Levi & Korsinsky, LLP notifies investors in Skye Bioscience, Inc. ("Skye Bioscience, Inc." or the "Company") of a class action securities ...
Summary • Skye Bioscience, Inc. (SKYE) sees a 12% pre-market increase, now priced at $0.9530.• Multiple class action lawsuits have been filed against SKYE, focusing on alleged securities fraud.• ...
An update from Skye Bioscience ( ($SKYE) ) is now available. On December 18, 2025, Skye Bioscience, Inc. entered into a non-exclusive ...
Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025, both dates inclusive (the ...
Skye Bioscience, Inc. is a clinical stage biopharmaceutical company that focuses on developing molecules that modulate G protein-coupled receptors ("GPCRs") to treat obesity, overweight, and metabolic ...
NEW YORK, NY / ACCESS Newswire / December 16, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ...
The Portnoy Law Firm advises Skye Bioscience, Inc., (“Skye” or the "Company") (NASDAQ: SKYE) investors of a class action on behalf of ...